HEALTH

Former Senator Ben Sasse Announces Terminal Cancer Diagnosis

PUBLISHED Dec 23, 2025, 12:07 PM ET

Read, Watch or Listen

Media Bias Meter

Sources: 11

Center 91%

Right 9%

Sources: 11

Lincoln, Neb. Former U.S. senator Ben Sasse on Tuesday announced he has been diagnosed with metastasized, stage-four pancreatic cancer and said the prognosis is terminal. Sasse, 53, wrote that he learned of the disease last week and that he is 'gonna die,' while noting he will pursue treatment and referenced immunotherapy advances. He served Nebraska in the Senate from 2015 to 2023 and resigned to become president of the University of Florida, stepping down the following year for family reasons and caregiving duties. Federal and state officials offered condolences and public support. Based on 11 articles reviewed and supporting research.

By Noormahi M. | JQJO News

Timeline of Events

2014: Ben Sasse elected U.S. Senator from Nebraska.
2020: Sasse wins reelection to the U.S. Senate.
January 2023: Resigns Senate seat to become University of Florida president.
2024: Steps down as UF president to focus on his wife’s health and family needs.
This week (Tuesday): Announces metastasized, stage-four pancreatic cancer diagnosis on social media.

Media Bias

Articles Published:: 11
Right Leaning:: 1
Left Leaning:: 0
Neutral:: 10
Distribution:: Left 0%, Center 91%, Right 9%

Who Benefited

Medical research organizations, oncology researchers, and patient advocacy groups may receive increased attention and potential funding as public focus on pancreatic cancer rises following Sasse's announcement.

Who Impacted

Ben Sasse, his immediate family, and close associates face significant emotional strain and complex medical and logistical challenges following his stage-four pancreatic cancer diagnosis.